These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 21710160)
1. Exploration of optimal teicoplanin dosage based on pharmacokinetic parameters for the treatment of intensive care unit patients infected with methicillin-resistant Staphylococcus aureus. Hagihara M; Umemura T; Kimura M; Mori T; Hasegawa T; Mikamo H J Infect Chemother; 2012 Feb; 18(1):10-6. PubMed ID: 21710160 [TBL] [Abstract][Full Text] [Related]
2. An initial dosing method for teicoplanin based on the area under the serum concentration time curve required for MRSA eradication. Kanazawa N; Matsumoto K; Ikawa K; Fukamizu T; Shigemi A; Yaji K; Shimodozono Y; Morikawa N; Takeda Y; Yamada K J Infect Chemother; 2011 Apr; 17(2):297-300. PubMed ID: 20714913 [TBL] [Abstract][Full Text] [Related]
3. Development of initial loading procedure for teicoplanin in critically ill patients with severe infections. Matsumoto K; Kanazawa N; Watanabe E; Yokoyama Y; Fukamizu T; Shimodozono Y; Maeda C; Yasuda T; Kakihana Y; Ikawa K; Morikawa N; Takeda Y Biol Pharm Bull; 2013; 36(6):1024-6. PubMed ID: 23727923 [TBL] [Abstract][Full Text] [Related]
4. Determination of teicoplanin trough concentration target and appropriate total dose during the first 3 days: a retrospective study in patients with MRSA infections. Matsumoto K; Kanazawa N; Ikawa K; Fukamizu T; Shigemi A; Yaji K; Shimodozono Y; Morikawa N; Takeda Y; Yamada K J Infect Chemother; 2010 Jun; 16(3):193-9. PubMed ID: 20195882 [TBL] [Abstract][Full Text] [Related]
5. Optimal teicoplanin dosage regimens for methicillin-resistant Staphylococcus aureus infections in endocarditis patients and renal failure patients. Li N; Zhu L; Xu G; Ge T; Qi F; Li M J Chemother; 2017 Dec; 29(6):358-364. PubMed ID: 28587526 [TBL] [Abstract][Full Text] [Related]
6. Clinical efficacy and safety in patients treated with teicoplanin with a target trough concentration of 20 μg/mL using a regimen of 12 mg/kg for five doses within the initial 3 days. Ueda T; Takesue Y; Nakajima K; Ichiki K; Ishikawa K; Takai Y; Yamada K; Tsuchida T; Otani N; Takahashi Y; Ishihara M; Takubo S; Ikeuchi H; Uchino M; Kimura T BMC Pharmacol Toxicol; 2020 Jul; 21(1):50. PubMed ID: 32641110 [TBL] [Abstract][Full Text] [Related]
7. Influence of teicoplanin MICs on treatment outcomes among patients with teicoplanin-treated methicillin-resistant Staphylococcus aureus bacteraemia: a hospital-based retrospective study. Chang HJ; Hsu PC; Yang CC; Siu LK; Kuo AJ; Chia JH; Wu TL; Huang CT; Lee MH J Antimicrob Chemother; 2012 Mar; 67(3):736-41. PubMed ID: 22169187 [TBL] [Abstract][Full Text] [Related]
8. Teicoplanin as an anti-methicillin resistant Staphylococcus aureus agent in infections of severely poisoned intensive care unit patients/ Tehran- Iran. Salimi A; Talaie H; Rezaie Hemami M; Mahdavinejad A; Barari BB; Razi P; Kamalbeik S Acta Biomed; 2014 Jan; 84(3):189-95. PubMed ID: 24458163 [TBL] [Abstract][Full Text] [Related]
9. Significance of individual adjustment of initial loading dosage of teicoplanin based on population pharmacokinetics. Niwa T; Imanishi Y; Ohmori T; Matsuura K; Murakami N; Itoh Y Int J Antimicrob Agents; 2010 May; 35(5):507-10. PubMed ID: 20185275 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of factors associated with the achievement of an optimal teicoplanin trough concentration . Takechi K; Yanagawa H; Zamami Y; Ishizawa K; Tanaka A; Araki H Int J Clin Pharmacol Ther; 2017 Aug; 55(8):672-677. PubMed ID: 28655381 [TBL] [Abstract][Full Text] [Related]
11. [Possibility of Poor Outcomes after Treatment Using Teicoplanin at the Minimum Inhibitory Concentration of >2 μg/mL in Methicillin-resistant Staphylococcus aureus Bacteremia]. Kagami K; Imai S; Tazawa Y; Iwasaki S; Fukumoto T; Akizawa K; Yamada T; Ishiguro N; Iseki K Yakugaku Zasshi; 2018; 138(9):1181-1189. PubMed ID: 30175762 [TBL] [Abstract][Full Text] [Related]
12. Population pharmacokinetic and pharmacodynamic analyses of teicoplanin in Japanese patients with systemic MRSA infection. Ogawa R; Kobayashi S; Sasaki Y; Makimura M; Echizen H Int J Clin Pharmacol Ther; 2013 May; 51(5):357-66. PubMed ID: 23458228 [TBL] [Abstract][Full Text] [Related]
13. High-dose regimen to achieve novel target trough concentration in teicoplanin. Ueda T; Takesue Y; Nakajima K; Ichki K; Wada Y; Komatsu M; Tsuchida T; Takahashi Y; Ishihara M; Kimura T; Uchino M; Ikeuchi H J Infect Chemother; 2014 Jan; 20(1):43-7. PubMed ID: 24462424 [TBL] [Abstract][Full Text] [Related]
14. Recommended initial loading dose of teicoplanin, established by therapeutic drug monitoring, and outcome in terms of optimal trough level. Sato M; Chida K; Suda T; Muramatsu H; Suzuki Y; Hashimoto H; Gemma H; Nakamura H J Infect Chemother; 2006 Aug; 12(4):185-9. PubMed ID: 16944256 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of teicoplanin dosing designs to achieve a new target trough concentration. Ueda T; Takesue Y; Nakajima K; Ichki K; Wada Y; Tsuchida T; Takahashi Y; Ishihara M; Tatsumi S; Kimura T; Ikeuchi H; Uchino M J Infect Chemother; 2012 Jun; 18(3):296-302. PubMed ID: 22065089 [TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetic-pharmacodynamic relationship of arbekacin for treatment of patients infected with methicillin-resistant Staphylococcus aureus. Sato R; Tanigawara Y; Kaku M; Aikawa N; Shimizu K Antimicrob Agents Chemother; 2006 Nov; 50(11):3763-9. PubMed ID: 17065622 [TBL] [Abstract][Full Text] [Related]
17. Optimal trough concentration of teicoplanin for the treatment of methicillin-resistant Staphylococcus aureus infection: A systematic review and meta-analysis. Hanai Y; Takahashi Y; Niwa T; Mayumi T; Hamada Y; Kimura T; Matsumoto K; Fujii S; Takesue Y J Clin Pharm Ther; 2021 Jun; 46(3):622-632. PubMed ID: 33547647 [TBL] [Abstract][Full Text] [Related]
18. Methicillin-resistant Staphylococcus aureus nasal colonization is a poor predictor of intensive care unit-acquired methicillin-resistant Staphylococcus aureus infections requiring antibiotic treatment. Sarikonda KV; Micek ST; Doherty JA; Reichley RM; Warren D; Kollef MH Crit Care Med; 2010 Oct; 38(10):1991-5. PubMed ID: 20683260 [TBL] [Abstract][Full Text] [Related]
19. Association of the clinical efficacy of vancomycin with the novel pharmacokinetic parameter area under the trough level (AUTL) in elderly patients with hospital-acquired pneumonia. Fukumori S; Tsuji Y; Mizoguchi A; Kasai H; Ishibashi T; Iwamura N; To H J Clin Pharm Ther; 2016 Aug; 41(4):399-402. PubMed ID: 27144370 [TBL] [Abstract][Full Text] [Related]
20. [Effect of pharmacists' intervention on the antibiotic therapy for the methicillin-resistant Staphylococcus aureus (MRSA) infectious diseases in the intensive care unit]. Imaura M; Kohata Y; Kobayashi K; Takahashi H; Yokoyama H; Akase T; Yamada Y Yakugaku Zasshi; 2011 Apr; 131(4):563-70. PubMed ID: 21467796 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]